Full-Time

Quality Coordinator

Updated on 9/4/2026

Perceptive

Perceptive

1,001-5,000 employees

Imaging core labs and eClinical solutions

No salary listed

London, UK

In Person

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Microsoft Office
GMP
Quality Assurance (QA)
Excel/Numbers/Sheets

Get referred to Perceptive

See people who can refer or advise you

Requirements
  • Experience working in a Good Manufacturing Practice environment in manufacturing or research.
  • Experience in operations, quality control, or quality assurance within a pharmaceutical environment.
  • A good understanding of advising manufacturing or project teams from a quality and GxP compliance perspective.
  • A good understanding of Quality Management System maintenance, risk management, auditing, and computerized systems.
  • Education to degree level or an equivalent qualification.
  • Fluent English.
  • Intermediate proficiency in desktop software applications, including Microsoft Office, Excel, and Adobe PDF.
  • A good understanding of Good Manufacturing Practice within the pharmaceutical industry and the ability to apply regulatory standards and guidelines.
  • Advanced knowledge of Quality Management System elements and continuous improvement methodologies.
  • The ability to communicate quality issues and potential recommendations to various functional groups.
  • The ability to train and support new and less experienced Quality team members.
  • The ability to work independently and reliably in a fast-paced environment.
Responsibilities
  • Provide Good Practice Quality Assurance oversight at the radiopharmaceutical production and clinical trial imaging facility.
  • Support compliance with company and regulatory GxP requirements by overseeing deviation management, vendor management, change control, internal audits, and self-inspections.
  • Administer and maintain the Quality Management System in accordance with company procedures and applicable GxP standards and guidelines.
  • Deliver GxP Quality training to employees and contractors.
  • Contribute to identifying and implementing continuous process improvement initiatives across business units.
  • Support the use and administration of the Quality Management System.
  • Ensure delivery of commitments to clients and sponsors in accordance with established Quality Agreements.
  • Participate in regulatory assessments as required.
  • Perform quality oversight of the deviation management system and ensure investigations identify root causes.
  • Critically review Corrective and Preventive Actions to ensure they are fit for purpose and linked to the original event.
  • Coordinate, track, review, and support approval of deviation investigations and out-of-specification events in accordance with Quality Management System requirements.
  • Approve and issue batch records and other GxP documents as required.
  • Coordinate issuance and tracking of controlled documents.
  • Issue batch documents and collate and review post-manufacture records to ensure Good Manufacturing Practice standards are maintained.
  • Collate completed Good Manufacturing Practice documentation and coordinate associated archiving activities.
  • Document vendor quality-system risk assessments through on-site audits, questionnaires, or other tools.
  • Ensure designated vendors are audited regularly and escalate vendor quality issues and risks to management.
  • Coordinate vendor qualification and audit schedules.
  • Arrange and perform supplier and vendor audits.
  • Provide subject matter expertise on vendor management practices during client audits.
  • Provide Quality Assurance support during regulatory inspections and client audits.
  • Complete internal audits and self-inspections.
  • Track completion of Good Manufacturing Practice self-inspections and audits.
  • Track actions arising from inspections, audits, and self-inspections.
  • Generate quality metrics and trend data to support ongoing compliance management through the Quality Compliance Council.
  • Perform training relating to quality systems and GxP.
  • Perform Quality Assurance release of product.
  • Perform Good Manufacturing Practice review and approval of batch records and other completed Good Manufacturing Practice records.
  • Identify opportunities to improve processes for quality, compliance, and business efficiency.
  • Implement initiatives that benefit quality, compliance, and business efficiency.
  • Provide quality oversight for risk identification and assessment processes.
Desired Qualifications
  • Knowledge of sterile manufacturing.
  • Experience working in radiopharmaceuticals.
  • Chemistry or Life Sciences degree or equivalent qualification.

Generate a clear, concise company summary for Perceptive based on the provided description.

Company Size

1,001-5,000

Company Stage

Late Stage VC

Total Funding

$15M

Headquarters

New Haven, Connecticut

Founded

2000

Get referred to Perceptive

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Perceptive Discovery launched α-Sight in April 2026 with MH3D, targeting oncology radioligands.
  • January 2026 brought $15 million for At-211 infrastructure across U.S. and U.K. sites.
  • April 2026 Trialzen and Kayentis alliances broaden Perceptive eClinical's commercialization and integration reach.

What critics are saying

  • Palantir's 2026 lawsuit against Percepta AI highlights talent-poaching and confidentiality vulnerability.
  • WCG and other imaging consolidators keep compressing Perceptive's core-lab pricing power.
  • If Perceptive misses alpha-imaging execution, CapVest's 2026 investment stops scaling returns.

What makes Perceptive unique

  • Perceptive spans discovery, imaging, and RTSM across one R&D workflow.
  • Its 2026 α-Sight partnership adds rare alpha-radiopharmaceutical imaging for Actinium-225 and Astatine-211.
  • Perceptive's 50-year lineage and 400-plus approvals signal embedded regulatory credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Flexible Work Hours

Remote Work Options

Health Savings Account/Flexible Spending Account

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Family Planning Benefits

Fertility Treatment Support

Conference Attendance Budget

Professional Development Budget

Stock Options

Company Equity

Adoption Assistance

Paid Holidays

Parental Leave

Education allowance

Tuition Reimbursement

Meal Benefits

Cycle to work scheme

Season ticket loan

Cycle to work scheme

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
PR Newswire
Apr 15th, 2026
Perceptive Discovery partners with MH3D to launch α-Sight™ for alpha radiopharmaceutical imaging

Perceptive Discovery has partnered with MH3D to launch α-Sight™, a preclinical imaging service for visualising alpha-emitting radiopharmaceuticals. The offering addresses imaging limitations in alpha-emitting therapies, which are increasingly used in oncology, by providing high-sensitivity, quantitative whole-body imaging. α-Sight™ combines MH3D's Alpha-SPECT™ Mini platform with Perceptive Discovery's expertise in preclinical imaging and radiochemistry. The service supports multi-isotope imaging for therapies using Actinium-225 and Astatine-211, integrated with VivoQuant™ for advanced analysis. Perceptive Discovery will serve as MH3D's exclusive service provider whilst collaborating on product enhancements. The platform supports biodistribution studies, tumour targeting validation and pharmacokinetic assessment to accelerate radioligand therapy development.

PR Newswire
Jan 8th, 2026
Perceptive Discovery secures $15M to expand radiochemistry and cell assay capabilities

Perceptive Discovery, the preclinical services division of Perceptive, has announced $15 million in strategic investments from shareholder CapVest Partners to expand its radiochemistry, cell assay and in vitro biology capabilities. The funding will support development services for oncology and radiopharmaceutical programmes from discovery through early clinical translation. The investment will significantly expand Perceptive Discovery's Astatine-211 infrastructure globally across two sites in the US and UK. The new facilities will feature specialised research environments and dedicated scientific personnel to support At-211 labelling, method development and preclinical applications. The investment underscores CapVest's confidence in Perceptive Discovery's business potential and reinforces the company's commitment to delivering integrated, high-quality preclinical workflows for drug development programmes.